Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Scott Letendre

    TitleTeacher
    SchoolUniversity of California, San Diego
    Address200 W. Arbor Drive #8208
    CA San Diego 92103
    Phone619-543-4730
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Sustained Training in Aging and HIV Research (STAHR)
      NIH/NIMH R25MH108389Apr 1, 2016 - Feb 28, 2021
      Role: Principal Investigator
      Age related determinants of HAND: A 12 year follow-up of CHARTER participants
      NIH/NIMH R01MH107345Sep 24, 2015 - Jun 30, 2020
      Role: Principal Investigator
      Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
      NIH/NIMH K24MH097673Dec 7, 2012 - Nov 30, 2017
      Role: Principal Investigator
      Milliplex FlexMAP 3D
      NIH/NCRR S10RR031646May 1, 2011 - Apr 30, 2012
      Role: Principal Investigator
      Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China
      NIH/NIMH R01MH092225Jul 15, 2010 - May 31, 2015
      Role: Principal Investigator
      Antiretroviral-Induced Immune Recovery and the Central Nervous System
      NIH/NIMH R21MH085610Mar 9, 2009 - Jan 31, 2012
      Role: Principal Investigator
      Neurocognitive Effects of HCV, HIV, and Drug Use
      NIH/NIDA R01DA016015Sep 30, 2002 - Dec 31, 2006
      Role: Principal Investigator
      HIV Neurobehavioral Research Center
      NIH/NIMH P30MH062512Apr 24, 2001 - Feb 28, 2021
      Role: Co-Investigator
      MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNA
      NIH/NIMH K23MH001779Sep 10, 1999 - Aug 31, 2005
      Role: Principal Investigator
      NEUROAIDS: EFFECTS OF METHAMPHETAMINE AND HCV
      NIH/NIDA P01DA012065Jul 1, 1999 - Apr 30, 2011
      Role: Co-Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK. Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. J Int Neuropsychol Soc. 2017 Sep 06; 1-13. PMID: 28874213.
        View in: PubMed
      2. Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, Letendre S, Heaton R, Mayo N. Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection. J Acquir Immune Defic Syndr. 2017 Sep 01; 76(1):48-54. PMID: 28797021.
        View in: PubMed
      3. Anderson AM, Schein TN, Kalapila A, Lai L, Waldrop-Valverde D, Moore RC, Franklin D, Letendre S, Barnum SR. Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives. J Neuroimmunol. 2017 Oct 15; 311:35-39. PMID: 28774464.
        View in: PubMed
      4. Kamat R, McCutchan A, Kumarasamy N, Marcotte TD, Umlauf A, Selvamuthu P, Meyer R, Letendre S, Heaton R, Bharti AR. Neurocognitive functioning among HIV-positive adults in southern India. J Neurovirol. 2017 Jul 05. PMID: 28681344.
        View in: PubMed
      5. Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte T, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, Tharakan R, McArthur JC, Fox H, Haughey NJ. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 06 19; 31(10):1365-1378. PMID: 28574961.
        View in: PubMed
      6. Yu C, Seaton M, Letendre S, Heaton R, Al-Harthi L. Plasma dickkopf-related protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment. AIDS. 2017 Jun 19; 31(10):1379-1385. PMID: 28358733.
        View in: PubMed
      7. Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre S, Heaton RK, Perry W. Everyday functional ability in HIV and methamphetamine dependence. Drug Alcohol Depend. 2017 Jun 01; 175:60-66. PMID: 28399475.
        View in: PubMed
      8. Montoya JL, Iudicello J, Oppenheim HA, Fazeli PL, Potter M, Ma Q, Mills PJ, Ellis RJ, Grant I, Letendre S, Moore DJ. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2017 Mar 27; 31(6):787-795. PMID: 28099190.
        View in: PubMed
      9. Sakoda ME, Fazeli PL, Ellis RJ, Jeste DV, Grant I, Letendre S, Moore DJ. Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):243-249. PMID: 27861242.
        View in: PubMed
      10. Montoya JL, Iudicello J, Fazeli PL, Hong S, Potter M, Ellis RJ, Grant I, Letendre S, Moore DJ. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141. PMID: 27828873.
        View in: PubMed
      11. Oliveira MF, Chaillon A, Nakazawa M, Vargas M, Letendre S, Strain MC, Ellis RJ, Morris S, Little SJ, Smith DM, Gianella S. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations. PLoS Pathog. 2017 Jan; 13(1):e1006112. PMID: 28046096.
        View in: PubMed
      12. Wagner GA, Chaillon A, Liu S, Franklin DR, Caballero G, Kosakovsky Pond SL, Vaida F, Heaton RK, Letendre S, Grant I, Richman DD, Smith DM. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 Nov 13; 30(17):2591-2597. PMID: 27536983.
        View in: PubMed
      13. de Almeida SM, Rotta I, Ribeiro CE, Smith D, Wang R, Judicello J, Potter M, Vaida F, Letendre S, Ellis RJ. Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. J Neuroimmunol. 2016 Dec 15; 301:41-48. PMID: 27836178.
        View in: PubMed
      14. Bharti AR, McCutchan A, Deutsch R, Smith DM, Ellis RJ, Cherner M, Woods SP, Heaton RK, Grant I, Letendre S. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults. Clin Infect Dis. 2016 Dec 15; 63(12):1655-1660. PMID: 27794019.
        View in: PubMed
      15. Keegan MR, Chittiprol S, Letendre S, Winston A, Fuchs D, Boasso A, Iudicello J, Ellis RJ. Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals. Int J Tryptophan Res. 2016; 9:79-88. PMID: 27812290.
        View in: PubMed
      16. Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre S. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. J Infect Dis. 2017 Jan 01; 215(1):105-113. PMID: 27789723.
        View in: PubMed
      17. Hoenigl M, Pérez-Santiago J, Nakazawa M, de Oliveira MF, Zhang Y, Finkelman MA, Letendre S, Smith D, Gianella S. (1?3)-ß-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection? Front Immunol. 2016; 7:404. PMID: 27752257.
        View in: PubMed
      18. Gianella S, Letendre S. Cytomegalovirus and HIV: A Dangerous Pas de Deux. J Infect Dis. 2016 Oct 01; 214 Suppl 2:S67-74. PMID: 27625433.
        View in: PubMed
      19. Samuels DC, Kallianpur AR, Ellis RJ, Bush WS, Letendre S, Franklin D, Grant I, Hulgan T. European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. Pathog Immun. 2016 Fall-Winter; 1(2):330-351. PMID: 28317034.
        View in: PubMed
      20. Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. J Neurovirol. 2017 Feb; 23(1):67-78. PMID: 27557777.
        View in: PubMed
      21. Gianella S, Kosakovsky Pond SL, Oliveira MF, Scheffler K, Strain MC, De la Torre A, Letendre S, Smith DM, Ellis RJ. Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy. Virus Evol. 2016 Jul; 2(2):vew020. PMID: 27774305.
        View in: PubMed
      22. de Almeida SM, Rotta I, Jiang Y, Li X, Raboni SM, Ribeiro CE, Smith D, Potter M, Vaida F, Letendre S, Ellis RJ. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol. 2016 Dec; 22(6):715-724. PMID: 27400932.
        View in: PubMed
      23. Ellis R, Letendre S. Update and New Directions in Therapeutics for Neurological Complications of HIV Infections. Neurotherapeutics. 2016 Jul; 13(3):471-6. PMID: 27383150; PMCID: PMC4965416 [Available on 07/01/17].
      24. Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre S, Gisslén M. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016; 11(6):e0157160. PMID: 27295036; PMCID: PMC4905676.
      25. Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre S, Grant I, Moore DJ. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 Sep 01; 63(5):694-702. PMID: 27199461; PMCID: PMC4981756 [Available on 09/01/17].
      26. Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre S. Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV AIDS (Auckl). 2016; 8:93-9. PMID: 27199571; PMCID: PMC4857802.
      27. Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM. Apolipoprotein E e4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol. 2016 Oct; 22(5):607-614. PMID: 27021072.
        View in: PubMed
      28. Royal W, Cherner M, Burdo TH, Umlauf A, Letendre S, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria. PLoS One. 2016; 11(2):e0147182. PMID: 26829391; PMCID: PMC4734765.
      29. de Oliveira MF, Murrell B, Pérez-Santiago J, Vargas M, Ellis RJ, Letendre S, Grant I, Smith DM, Woods SP, Gianella S. Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART. Sci Rep. 2016 Jan 19; 6:19387. PMID: 26783252; PMCID: PMC4726116.
      30. Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre S, Marra CM, Morgello S, Simpson DM, Mcarthur JC. Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study. J Neurovirol. 2016 Aug; 22(4):479-87. PMID: 26727907; PMCID: PMC4925276 [Available on 08/01/17].
      31. Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre S. Lower CSF Aß is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res. 2016; 14(4):324-30. PMID: 26673902; PMCID: PMC4916008 [Available on 01/01/17].
      32. Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre S, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 Apr 01; 213(7):1065-73. PMID: 26690344; PMCID: PMC4779306 [Available on 04/01/17].
      33. Bryant AK, Fazeli PL, Letendre S, Ellis RJ, Potter M, Burdo TH, Singh KK, Jeste DV, Grant I, Moore DJ. Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive Adults. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):271-8. PMID: 26499082; PMCID: PMC4779974 [Available on 03/01/17].
      34. de Oliveira MF, Murrell B, Murrel B, Pérez-Santiago J, Vargas M, Ellis RJ, Letendre S, Grant I, Smith DM, Woods SP, Gianella S. Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART. Sci Rep. 2015 Nov 25; 5:17094. PMID: 26603568; PMCID: PMC4658529.
      35. Carvalhal A, Gill MJ, Letendre S, Rachlis A, Bekele T, Raboud J, Burchell A, Rourke SB. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neurovirol. 2016 Jun; 22(3):349-57. PMID: 26572786.
        View in: PubMed
      36. de Oliveira MF, Gianella S, Letendre S, Scheffler K, Kosakovsky Pond SL, Smith DM, Strain M, Ellis RJ. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR. PLoS One. 2015; 10(10):e0139510. PMID: 26431315; PMCID: PMC4592012.
      37. Pérez-Santiago J, Schrier RD, de Oliveira MF, Gianella S, Var SR, Day TR, Ramirez-Gaona M, Suben JD, Murrell B, Massanella M, Cherner M, Smith DM, Ellis RJ, Letendre S, Mehta SR. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection. J Neurovirol. 2016 Apr; 22(2):191-200. PMID: 26428514; PMCID: PMC4862614 [Available on 04/01/17].
      38. Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre S. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016 Apr; 22(2):170-8. PMID: 26407716; PMCID: PMC4783211 [Available on 04/01/17].
      39. Day TR, Smith DM, Heaton RK, Franklin D, Tilghman MW, Letendre S, Jin H, Wu Z, Shi C, Yu X, Pérez-Santiago J. Subtype associations with HIV-associated neurocognitive disorder in China. J Neurovirol. 2016 Apr; 22(2):246-50. PMID: 26306690; PMCID: PMC4769127 [Available on 04/01/17].
      40. Hestad KA, Menon JA, Serpell R, Kalungwana L, Mwaba SO, Kabuba N, Franklin DR, Umlauf A, Letendre S, Heaton RK. Do neuropsychological test norms from African Americans in the United States generalize to a Zambian population? Psychol Assess. 2016 Jan; 28(1):18-38. PMID: 26146950; PMCID: PMC4703578 [Available on 01/01/17].
      41. Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre S, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Clin Infect Dis. 2015 Nov 01; 61(9):1476-84. PMID: 26129753; PMCID: PMC4599391 [Available on 11/01/16].
      42. Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre S. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 Oct; 21(5):559-67. PMID: 26069183; PMCID: PMC5008689 [Available on 10/01/16].
      43. Dickens AM, Anthony DC, Deutsch R, Mielke MM, Claridge TD, Grant I, Franklin D, Rosario D, Marcotte T, Letendre S, McArthur JC, Haughey NJ. Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS. 2015 Mar 13; 29(5):559-69. PMID: 25611149; PMCID: PMC4340743.
      44. Ghate M, Mehendale S, Meyer R, Umlauf A, Deutsch R, Kamat R, Thakar M, Risbud A, Kulkarni S, Sakamoto M, Alexander T, Franklin D, Letendre S, Heaton RK, Grant I, Marcotte TD. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India. J Neurovirol. 2015 Aug; 21(4):391-8. PMID: 25750072; PMCID: PMC4512904.
      45. Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, Clifford D, Morgello S, Grant I, McCutchan JA. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 Mar 01; 68(3):281-8. PMID: 25469522; PMCID: PMC4551458.
      46. Moore DJ, Poquette A, Casaletto KB, Gouaux B, Montoya JL, Posada C, Rooney AS, Badiee J, Deutsch R, Letendre S, Depp CA, Grant I, Atkinson JH. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015 Mar; 19(3):459-71. PMID: 25504449; PMCID: PMC4359057.
      47. Schrier RD, Hong S, Crescini M, Ellis R, Pérez-Santiago J, Spina C, Letendre S. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS One. 2015; 10(2):e0116526. PMID: 25719800; PMCID: PMC4342256.
      48. Kesby JP, Heaton RK, Young JW, Umlauf A, Woods SP, Letendre S, Markou A, Grant I, Semenova S. Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Neuropsychopharmacology. 2015 Jul; 40(8):1899-909. PMID: 25652249; PMCID: PMC4839513.
      49. Clifford DB, Vaida F, Kao YT, Franklin DR, Letendre S, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 Jan 20; 84(3):241-50. PMID: 25503616; PMCID: PMC4335996.
      50. Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014 Nov; 13(11):1139-1151. PMID: 25316020; PMCID: PMC4313542.
      51. Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 Feb 01; 60(3):473-80. PMID: 25362201; PMCID: PMC4303775.
      52. Cattie JE, Letendre S, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. J Neurovirol. 2014 Dec; 20(6):561-70. PMID: 25326107; PMCID: PMC4367960.
      53. Kamat R, Brown GG, Bolden K, Fennema-Notestein C, Archibald S, Marcotte TD, Letendre S, Ellis RJ, Woods SP, Grant I, Heaton RK. Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection. J Clin Exp Neuropsychol. 2014; 36(8):854-66. PMID: 25275424; PMCID: PMC4303236.
      54. Gongvatana A, Morgan EE, Iudicello JE, Letendre S, Grant I, Woods SP. A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older. J Neurovirol. 2014 Oct; 20(5):505-13. PMID: 25201556; PMCID: PMC4206568.
      55. Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I. Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy. PLoS One. 2014; 9(8):e103123. PMID: 25144566; PMCID: PMC4140681.
      56. Almeida SM, Marquie-Beck J, Bhatt A, Letendre S, McCutchan A, Ellis R. Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - method-comparison evaluations. Arq Neuropsiquiatr. 2014 Jul; 72(7):500-5. PMID: 25054981; PMCID: PMC4259897.
      57. Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, Morgello S, Simpson DM, Gelman BB, Ellis RJ, Grant I, Letendre S, McArthur JC. The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. Am J Epidemiol. 2014 Aug 01; 180(3):297-307. PMID: 24966216; PMCID: PMC4108039.
      58. Letendre S, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, Song IH, Piscitelli SC. ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis. 2014 Oct; 59(7):1032-7. PMID: 24944232; PMCID: PMC4166983.
      59. Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 Jun 10; 82(23):2055-62. PMID: 24814848; PMCID: PMC4118496.
      60. Barteselli G, Chhablani J, Gomez ML, Doede AL, Dustin L, Kozak I, Bartsch DU, Azen SP, Letendre S, Freeman WR. Visual function assessment in simulated real-life situations in HIV-infected subjects. PLoS One. 2014; 9(5):e97023. PMID: 24809827; PMCID: PMC4014600.
      61. Iudicello JE, Morgan EE, Gongvatana A, Letendre S, Grant I, Woods SP. Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect? J Neurovirol. 2014 Feb; 20(1):85-98. PMID: 24470237; PMCID: PMC3949511.
      62. Gupta S, Iudicello JE, Shi C, Letendre S, Knight A, Li J, Riggs PK, Franklin DR, Duarte N, Jin H, Hampton Atkinson J, Yu X, Wu Z, Grant I, Heaton RK. Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. Drug Alcohol Depend. 2014 Apr 01; 137:29-35. PMID: 24508003; PMCID: PMC3961522.
      63. Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA. Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis. 2014 Apr; 58(7):1015-22. PMID: 24352352; PMCID: PMC3952601.
      64. Doyle KL, Morgan EE, Morris S, Smith DM, Little S, Iudicello JE, Blackstone K, Moore DJ, Grant I, Letendre S, Woods SP. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol. 2013 Dec; 19(6):565-73. PMID: 24277439; PMCID: PMC3865175.
      65. Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre S, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency. Psychiatry Res. 2014 Jan 30; 215(1):208-16. PMID: 24290100; PMCID: PMC3967865.
      66. Marcotte TD, Deutsch R, Michael BD, Franklin D, Cookson DR, Bharti AR, Grant I, Letendre S. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 Dec; 8(5):1123-35. PMID: 24101401; PMCID: PMC3874146.
      67. Morris SR, Woods SP, Deutsch R, Little SJ, Wagner G, Morgan EE, Heaton RK, Letendre S, Grant I, Smith DM. Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits. J Neurovirol. 2013 Oct; 19(5):488-94. PMID: 24078557; PMCID: PMC3921071.
      68. Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau DJ, Wolfson T, Heaton RK, Gamst AC, Franklin DR, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 Aug; 19(4):393-401. PMID: 23838849; PMCID: PMC3776609.
      69. Hoffman JT, Rossi SS, Espina-Quinto R, Letendre S, Capparelli EV. Determination of efavirenz in human dried blood spots by reversed-phase high-performance liquid chromatography with UV detection. Ther Drug Monit. 2013 Apr; 35(2):203-8. PMID: 23503446; PMCID: PMC3848783.
      70. Jin H, Atkinson JH, Duarte NA, Yu X, Shi C, Riggs PK, Li J, Gupta S, Wolfson T, Knight AF, Franklin D, Letendre S, Wu Z, Grant I, Heaton RK. Risks and predictors of current suicidality in HIV-infected heroin users in treatment in Yunnan, China: a controlled study. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):311-6. PMID: 23196829; PMCID: PMC3975910.
      71. Nguyen A, Rossi S, Croteau D, Best BM, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Ellis RJ, Grant I, Capparelli E, Letendre S. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 May; 68(5):1161-8. PMID: 23335197; PMCID: PMC3625433.
      72. Crum-Cianflone NF, Moore DJ, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9. PMID: 23303852; PMCID: PMC3589242.
      73. Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre S, Grant I, Woods SP. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS. 2013 Jan; 27(1):5-16. PMID: 23305257; PMCID: PMC3545369.
      74. Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson D, Grant I. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 Jan 01; 62(1):36-42. PMID: 23111573; PMCID: PMC3529802.
      75. Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre S, Little S, Morris S, Smith DM, Moore DJ, Woods SP. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol. 2013 Feb; 19(1):65-74. PMID: 23250704; PMCID: PMC3568179.
      76. Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S. Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother. 2013 Mar; 68(3):684-9. PMID: 23143899; PMCID: PMC3566670.
      77. Moore DJ, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre S, Crum-Cianflone NF. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012; 7(11):e47310. PMID: 23144815; PMCID: PMC3493574.
      78. Moore DJ, Posada C, Parikh M, Arce M, Vaida F, Riggs PK, Gouaux B, Ellis RJ, Letendre S, Grant I, Atkinson JH. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66. PMID: 22041931; PMCID: PMC3351543.
      79. Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I. Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012 Dec; 18(6):511-20. PMID: 23073667; PMCID: PMC3587171.
      80. Hightower GK, Wong JK, Letendre S, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 Nov 25; 433(2):498-505. PMID: 22999095; PMCID: PMC3466337.
      81. Bharti AR, Saravanan S, Madhavan V, Smith DM, Sharma J, Balakrishnan P, Letendre S, Kumarasamy N. Correlates of HIV and malaria co-infection in Southern India. Malar J. 2012 Sep 03; 11:306. PMID: 22943054; PMCID: PMC3504568.
      82. Perez-Valero I, Cysique L, Letendre S, Heaton R. Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy". HIV Clin Trials. 2012 Sep-Oct; 13(5):296-8; author reply 299-300. PMID: 23134631.
        View in: PubMed
      83. Schrier RD, Gupta S, Riggs P, Cysique LA, Letendre S, Jin H, Spector SA, Singh KK, Wolfson T, Wu Z, Hong KX, Yu X, Shi C, Heaton RK. The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China. PLoS One. 2012; 7(5):e32303. PMID: 22693541; PMCID: PMC3365058.
      84. Archibald SL, Jacobson MW, Fennema-Notestine C, Ogasawara M, Woods SP, Letendre S, Grant I, Jernigan TL. Functional interactions of HIV-infection and methamphetamine dependence during motor programming. Psychiatry Res. 2012 Apr 30; 202(1):46-52. PMID: 22608157; PMCID: PMC3380171.
      85. Morgan EE, Woods SP, Rooney A, Perry W, Grant I, Letendre S. Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. Clin Neuropsychol. 2012; 26(4):654-74. PMID: 22533778; PMCID: PMC3412152.
      86. Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Grant I. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 Apr 24; 26(7):890-3. PMID: 22313954; PMCID: PMC3454507.
      87. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre S, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 Apr; 18(2):81-90. PMID: 22528397; PMCID: PMC3572198.
      88. Best BM, Letendre S, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Capparelli EV, Ellis RJ, Grant I. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 Apr 01; 59(4):376-81. PMID: 22217676; PMCID: PMC3299895.
      89. Crum-Cianflone NF, Roediger MP, Moore DJ, Hale B, Weintrob A, Ganesan A, Eberly LE, Johnson E, Agan BK, Letendre S. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012 May; 54(10):1485-94. PMID: 22431801; PMCID: PMC3334363.
      90. Pottiez G, Jagadish T, Yu F, Letendre S, Ellis R, Duarte NA, Grant I, Gendelman HE, Fox HS, Ciborowski P. Plasma proteomic profiling in HIV-1 infected methamphetamine abusers. PLoS One. 2012; 7(2):e31031. PMID: 22359561; PMCID: PMC3281056.
      91. Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Way L, Capparelli E, Grant I. Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 Apr; 56(4):1985-9. PMID: 22290964; PMCID: PMC3318381.
      92. Posada C, Moore DJ, Deutsch R, Rooney A, Gouaux B, Letendre S, Grant I, Atkinson JH. Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder. J Neuropsychiatry Clin Neurosci. 2012; 24(1):61-70. PMID: 22450615; PMCID: PMC3575087.
      93. Kamat R, Ghate M, Gollan TH, Meyer R, Vaida F, Heaton RK, Letendre S, Franklin D, Alexander T, Grant I, Mehendale S, Marcotte TD. Effects of Marathi-Hindi bilingualism on neuropsychological performance. J Int Neuropsychol Soc. 2012 Mar; 18(2):305-13. PMID: 22206622; PMCID: PMC3581332.
      94. Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011 Nov; 19(4):137-42. PMID: 22156215; PMCID: PMC4666587.
      95. Bharti AR, Letendre S, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, Simpson D, Ellis RJ, Grant I. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 Dec; 52(4):328-32. PMID: 21924674; PMCID: PMC3217127.
      96. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 Sep 10; 25(14):1747-51. PMID: 21750419; PMCID: PMC3867631.
      97. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis. 2011 Jul 01; 204(1):154-63. PMID: 21628670; PMCID: PMC3105035.
      98. Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E. Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. J Neurovirol. 2011 Aug; 17(4):327-40. PMID: 21660601; PMCID: PMC3919659.
      99. Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neurovirol. 2011 Aug; 17(4):368-79. PMID: 21556960; PMCID: PMC4309645.
      100. Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre S, Ellis RJ, Heaton RK, Gamst AC, Franklin DR, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 Jun; 17(3):248-57. PMID: 21544705; PMCID: PMC3702821.
      101. Cysique LA, Franklin D, Abramson I, Ellis RJ, Letendre S, Collier A, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011 Jun; 33(5):505-22. PMID: 21391011; PMCID: PMC3151558.
      102. Valcour V, Sithinamsuwan P, Letendre S, Ances B. Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep. 2011 Mar; 8(1):54-61. PMID: 21191673; PMCID: PMC3035797.
      103. Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011 Jan 28; 25(3):357-65. PMID: 21124201; PMCID: PMC3022370.
      104. Letendre S, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol. 2011 Feb; 17(1):63-9. PMID: 21246320; PMCID: PMC3032187.
      105. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre S, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 Feb; 17(1):3-16. PMID: 21174240; PMCID: PMC3032197.
      106. Moore DJ, Letendre S, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 Feb; 17(1):50-7. PMID: 21165782; PMCID: PMC3032208.
      107. Malaspina L, Woods SP, Moore DJ, Depp C, Letendre S, Jeste D, Grant I. Successful cognitive aging in persons living with HIV infection. J Neurovirol. 2011 Feb; 17(1):110-9. PMID: 21165783; PMCID: PMC3032198.
      108. Best BM, Koopmans PP, Letendre S, Capparelli EV, Rossi SS, Clifford DB, Collier AC, Gelman BB, Mbeo G, McCutchan JA, Simpson DM, Haubrich R, Ellis R, Grant I. Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother. 2011 Feb; 66(2):354-7. PMID: 21098541; PMCID: PMC3019085.
      109. Atkinson JH, Jin H, Shi C, Yu X, Duarte NA, Casey CY, Franklin DR, Vigil O, Cysique L, Wolfson T, Riggs PK, Gupta S, Letendre S, Marcotte TD, Grant I, Wu Z, Heaton RK. Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China. J Affect Disord. 2011 May; 130(3):421-8. PMID: 21094530; PMCID: PMC3307799.
      110. Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D, Collier A, Gelman B, Marra C, Mbeo G, McCutchan A, Morgello S, Simpson D, Way L, Vaida F, Ueland S, Capparelli E, Grant I. Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010 Dec; 54(12):5156-60. PMID: 20876368; PMCID: PMC2981289.
      111. Cherner M, Bousman C, Everall I, Barron D, Letendre S, Vaida F, Atkinson JH, Heaton R, Grant I. Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc. 2010 Sep; 16(5):890-901. PMID: 20727252; PMCID: PMC3543816.
      112. Posada C, Moore DJ, Woods SP, Vigil O, Ake C, Perry W, Hassanein TI, Letendre S, Grant I. Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J Clin Exp Neuropsychol. 2010 Jul; 32(6):637-44. PMID: 20603743; PMCID: PMC2898888.
      113. Spector SA, Singh KK, Gupta S, Cystique LA, Jin H, Letendre S, Schrier R, Wu Z, Hong KX, Yu X, Shi C, Heaton RK. APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS. 2010 Jun 19; 24(10):1471-9. PMID: 20442634; PMCID: PMC3063510.
      114. Robertson K, Liner J, Hakim J, Sankalé JL, Grant I, Letendre S, Clifford D, Diop AG, Jaye A, Kanmogne G, Njamnshi A, Langford TD, Weyessa TG, Wood C, Banda M, Hosseinipour M, Sacktor N, Nakasuja N, Bangirana P, Paul R, Joska J, Wong J, Boivin M, Holding P, Kammerer B, Van Rie A, Ive P, Nath A, Lawler K, Adebamowo C, Royal W, Joseph J. NeuroAIDS in Africa. J Neurovirol. 2010 May; 16(3):189-202. PMID: 20500018; PMCID: PMC3549534.
      115. Cysique LA, Letendre S, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson IS, Grant I, Heaton RK. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010 Apr 24; 24(7):983-90. PMID: 20299964; PMCID: PMC2898923.
      116. Letendre S, Ellis RJ, Ances BM, McCutchan JA. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010 Apr-May; 18(2):45-55. PMID: 20516524.
        View in: PubMed
      117. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2010 Mar; 16(2):185-8. PMID: 20443740; PMCID: PMC4386597.
      118. Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, McCutchan JA, Ellis RJ. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis. 2010 Feb 01; 201(3):336-40. PMID: 20047503; PMCID: PMC2804778.
      119. de Almeida SM, Bhatt A, Riggs PK, Durelle J, Lazzaretto D, Marquie-Beck J, McCutchan A, Letendre S, Ellis R. Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis. J Neurovirol. 2010 Feb; 16(1):6-12. PMID: 20132081; PMCID: PMC3076453.
      120. Woods SP, Iudicello JE, Dawson MS, Weber E, Grant I, Letendre S. HIV-associated deficits in action (verb) generation may reflect astrocytosis. J Clin Exp Neuropsychol. 2010 Jun; 32(5):522-7. PMID: 19844819; PMCID: PMC2878376.
      121. Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):154-63. PMID: 19815352; PMCID: PMC2814900.
      122. Hightower GK, Letendre S, Cherner M, Gibson SA, Ellis RJ, Wolfson TJ, Gamst AC, Ignacio CC, Heaton RK, Grant I, Richman DD, Smith DM. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance. Virology. 2009 Nov 25; 394(2):243-8. PMID: 19762060; PMCID: PMC3046809.
      123. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009 Jul 17; 23(11):1359-66. PMID: 19424052; PMCID: PMC2706549.
      124. Harrington PR, Schnell G, Letendre S, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009 May 15; 23(8):907-15. PMID: 19414991; PMCID: PMC3089803.
      125. Ances BM, Bhatt A, Vaida F, Rosario D, Alexander T, Marquie-Beck J, Ellis RJ, Letendre S, Grant I, McCutchan JA. Role of metabolic syndrome components in human immunodeficiency virus-associated stroke. J Neurovirol. 2009 May; 15(3):249-56. PMID: 19562611; PMCID: PMC2891579.
      126. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre S, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 Apr; 15(2):187-95. PMID: 19306228; PMCID: PMC3066173.
      127. Letendre S, Ellis RJ, Everall I, Ances B, Bharti A, McCutchan JA. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2009 Apr-May; 17(2):46-56. PMID: 19401607; PMCID: PMC3065886.
      128. Best BM, Letendre S, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 Jan 02; 23(1):83-7. PMID: 19050389; PMCID: PMC2642983.
      129. Smith DM, Zárate S, Shao H, Pillai SK, Letendre S, Wong JK, Richman DD, Frost SD, Ellis RJ. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 2009 Mar 01; 385(1):204-8. PMID: 19100592; PMCID: PMC2794037.
      130. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2008 Nov; 14(6):536-49. PMID: 18991068.
        View in: PubMed
      131. Childers ME, Woods SP, Letendre S, McCutchan JA, Rosario D, Grant I, Mindt MR, Ellis RJ. Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection. J Neurovirol. 2008 Nov; 14(6):550-7. PMID: 19016380; PMCID: PMC4692591.
      132. Letendre S, McCutchan JA, Ellis RJ. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2008 Apr-May; 16(1):15-22. PMID: 18441379.
        View in: PubMed
      133. Vigil O, Posada C, Woods SP, Atkinson JH, Heaton RK, Perry W, Hassanein TI, Grant I, Letendre S. Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol. 2008 Oct; 30(7):805-15. PMID: 18608687; PMCID: PMC2837785.
      134. Ances BM, Letendre S, Alexander T, Ellis RJ. Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. Int Rev Psychiatry. 2008 Feb; 20(1):89-93. PMID: 18240065.
        View in: PubMed
      135. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 Jan; 65(1):65-70. PMID: 18195140; PMCID: PMC2763187.
      136. Cachay ER, Moini N, Kosakovsky Pond SL, Pesano R, Lie YS, Aiem H, Butler DM, Letendre S, Mathews WC, Smith DM. Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. Open AIDS J. 2007; 1:5-10. PMID: 18923691; PMCID: PMC2556194.
      137. Vigil O, Woods SP, Moran LM, Letendre S, Young-Casey C, Grant I, Atkinson JH. Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence? Am J Addict. 2007 Sep-Oct; 16(5):418-23. PMID: 17882614.
        View in: PubMed
      138. Cysique LA, Jin H, Franklin DR, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc. 2007 Sep; 13(5):781-90. PMID: 17697409; PMCID: PMC2857379.
      139. Podzamczer D, King MS, Klein CE, Flexner C, Katlama C, Havlir DV, Letendre S, Eron JJ, Brun SC, Bernstein B. High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response. HIV Clin Trials. 2007 Jul-Aug; 8(4):193-204. PMID: 17720659.
        View in: PubMed
      140. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis. 2007 Aug 01; 196(3):361-70. PMID: 17597450.
        View in: PubMed
      141. Letendre S, Ances B, Gibson S, Ellis RJ. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2007 Apr-May; 15(2):32-9. PMID: 17485785.
        View in: PubMed
      142. Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre S, Grant I. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol. 2007 Apr; 13(2):150-9. PMID: 17505983.
        View in: PubMed
      143. Woods SP, Carey CL, Moran LM, Dawson MS, Letendre S, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 2007 Feb; 22(2):187-95. PMID: 17289343; PMCID: PMC1851919.
      144. May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R. Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar; 2(1):97-104. PMID: 18040832.
        View in: PubMed
      145. Letendre S, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007 Mar; 2(1):120-7. PMID: 18040835.
        View in: PubMed
      146. Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre S. Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol. 2006 Dec; 19(4):217-21. PMID: 17159619; PMCID: PMC1939824.
      147. McArthur JC, Letendre S. Is the glass three-quarters full or one-quarter empty? J Infect Dis. 2006 Dec 15; 194(12):1628-31. PMID: 17109332.
        View in: PubMed
      148. Ances BM, Letendre S, Buzzell M, Marquie-Beck J, Lazaretto D, Marcotte TD, Grant I, Ellis RJ. Valproic acid does not affect markers of human immunodeficiency virus disease progression. J Neurovirol. 2006 Oct; 12(5):403-6. PMID: 17065134.
        View in: PubMed
      149. Letendre S, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I. Lithium improves HIV-associated neurocognitive impairment. AIDS. 2006 Sep 11; 20(14):1885-8. PMID: 16954730.
        View in: PubMed
      150. Monteiro de Almeida S, Letendre S, Zimmerman J, Kolakowski S, Lazzaretto D, McCutchan JA, Ellis R. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. J Neuroimmunol. 2006 Oct; 179(1-2):180-5. PMID: 16901548.
        View in: PubMed
      151. de Almeida SM, Letendre S, Ellis R. Human immunodeficiency virus and the central nervous system. Braz J Infect Dis. 2006 Feb; 10(1):41-50. PMID: 16767315.
        View in: PubMed
      152. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006 Jul; 129(Pt 7):1872-83. PMID: 16735456.
        View in: PubMed
      153. Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol. 2006 Apr; 12(2):100-7. PMID: 16798671.
        View in: PubMed
      154. Letendre S, Ellis RJ. Neurologic complications of HIV disease and their treatments. Top HIV Med. 2006 Mar-Apr; 14(1):21-6. PMID: 16641524.
        View in: PubMed
      155. Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006 Jan; 28(1):13-28. PMID: 16448973.
        View in: PubMed
      156. Letendre S, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005 Oct; 19 Suppl 3:S72-8. PMID: 16251831.
        View in: PubMed
      157. Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan A, Ellis R. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J Neuroimmunol. 2005 Dec; 169(1-2):144-52. PMID: 16182380.
        View in: PubMed
      158. Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol. 2005 Aug; 11(4):356-64. PMID: 16206458.
        View in: PubMed
      159. Capparelli EV, Holland D, Okamoto C, Gragg B, Durelle J, Marquie-Beck J, van den Brande G, Ellis R, Letendre S. Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS. 2005 Jun 10; 19(9):949-52. PMID: 15905676.
        View in: PubMed
      160. Capparelli EV, Letendre S, Ellis RJ, Patel P, Holland D, McCutchan JA. Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid. Antimicrob Agents Chemother. 2005 Jun; 49(6):2504-6. PMID: 15917556; PMCID: PMC1140502.
      161. Singh KK, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol. 2004 Dec; 157(1-2):185-92. PMID: 15579296.
        View in: PubMed
      162. Letendre S, Marquie-Beck J, Singh KK, de Almeida S, Zimmerman J, Spector SA, Grant I, Ellis R. The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol. 2004 Dec; 157(1-2):193-6. PMID: 15579297.
        View in: PubMed
      163. Letendre S, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol. 2004 Sep; 56(3):416-23. PMID: 15349869.
        View in: PubMed
      164. Taylor MJ, Letendre S, Schweinsburg BC, Alhassoon OM, Brown GG, Gongvatana A, Grant I. Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc. 2004 Jan; 10(1):110-3. PMID: 14751013.
        View in: PubMed
      165. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003 Dec 15; 188(12):1820-6. PMID: 14673760.
        View in: PubMed
      166. Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12. PMID: 14568811.
        View in: PubMed
      167. Chardos JF, Smith D, Letendre S. Demyelinating encephalitis. Clin Infect Dis. 2003 May 15; 36(10):1266-7, 1332-4. PMID: 12760348.
        View in: PubMed
      168. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003 Jan; 9(1):64-71. PMID: 12570359.
        View in: PubMed
      169. Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol. 2002 Jun; 59(6):923-8. PMID: 12056927.
        View in: PubMed
      170. Langford TD, Letendre S, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS. 2002 May 03; 16(7):1019-29. PMID: 11953468; PMCID: PMC3548569.
      171. Letendre S, Lanier ER, McCutchan JA. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J Infect Dis. 1999 Aug; 180(2):310-9. PMID: 10395844.
        View in: PubMed
      Scott's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _